0001209191-22-002287.txt : 20220106
0001209191-22-002287.hdr.sgml : 20220106
20220106205801
ACCESSION NUMBER: 0001209191-22-002287
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220105
FILED AS OF DATE: 20220106
DATE AS OF CHANGE: 20220106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOZE BARRY
CENTRAL INDEX KEY: 0001619500
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 22516301
MAIL ADDRESS:
STREET 1: C/O HORIZON PHARMA, INC.
STREET 2: 520 EAST COOK ROAD, SUITE 520
CITY: DEERFIELD
STATE: IL
ZIP: 60015
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-05
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001619500
MOZE BARRY
C/O HORIZON THERAPEUTICS PLC,
70 SAINT STEPHEN?S GREEN
DUBLIN
L2
D02 E2X4
IRELAND
0
1
0
0
EVP, Chief Admin. Officer
Ordinary Shares
2022-01-05
4
M
0
64959
A
140640
D
Ordinary Shares
2022-01-05
4
A
0
47375
0.00
A
188015
D
Ordinary Shares
2022-01-05
4
F
0
49841
101.84
D
138174
D
Restricted Stock Units (RSU)
2022-01-05
4
M
0
24650
0.00
D
Ordinary Shares
24650
0
D
Restricted Stock Units (RSU)
2022-01-05
4
M
0
12095
0.00
D
Ordinary Shares
12095
12095
D
Restricted Stock Units (RSU)
2022-01-05
4
M
0
9314
0.00
D
Ordinary Shares
9314
18628
D
Restricted Stock Units (RSU)
2022-01-05
4
M
0
9222
0.00
D
Ordinary Shares
9222
9223
D
Restricted Stock Units (RSU)
2022-01-05
4
M
0
9678
0.00
D
Ordinary Shares
9678
4834
D
Each RSU represents a contingent right to receive one ordinary share of the Issuer.
On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2022, the PSUs vested as to the number of shares reported above.
The RSU's vest 1/3rd annually on each anniversary of January 5, 2019.
The RSU's vest 1/3rd annually on each anniversary of January 5, 2020.
The RSU's vest 1/3rd annually on each anniversary of January 5, 2021.
50% of the shares subject to the RSU's vested on 1/5/2022, and the remaining shares vest on 1/5/2023.
Two-thirds of the ordinary shares subject to the RSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023.
/s/ Miles W. McHugh, Attorney-in-Fact
2021-01-06